Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.

Lewis, James H

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. [electronic resource] - Hepatology (Baltimore, Md.) Nov 2007 - 1453-63 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial

1527-3350

10.1002/hep.21848 doi


Adult
Aged
Aged, 80 and over
Alanine Transaminase--blood
Anticholesteremic Agents--adverse effects
Cholesterol, HDL--blood
Cholesterol, LDL--blood
Chronic Disease
Double-Blind Method
Female
Humans
Hypercholesterolemia--blood
Liver--enzymology
Liver Diseases--complications
Male
Middle Aged
Pravastatin--adverse effects
Treatment Outcome
Triglycerides--blood